Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Eutilex
Eutilex is a t cell and antibody therapies founded in 2015.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
B2X
B2B
0
CEO
Byoung S. Kwon
0
Legal Name
Eutilex Co., Ltd.
Company Operating Status
Active
Country
South Korea
0
Crunchbase URL
crunchbase.com/organiz.../eutilex
Email Address
info@webmaker21.net
partnering@eutilex.com
0
whddbs1241@eutilex.com
0
whpark@eutilex.com
0
Fax Number
+82-2-2071-3399
Founded Date
2015
0
Full Address
Suite 408, Gasan digital 1-Ro 58, Geumcheon-gu, Seoul, Republic of Korea, 08591
0
Headquarters
Geumcheon District
0
Industry
Biology
Biotechnology
Internal medicine
Healthcare
Regenerative medicine
Medicine
Cell therapy
Stem cell
Oncology
Biomedical engineering
•••
Investors
SNU Bio Angel
DA Value Investment
Kolon Investment
DS Asset Management
G.N. Tech Venture
Latest Funding Round Date
December 8, 2016
Latest Funding Round Amount (USD)
18,900,000
Latest Funding Type
Series A
Legal classification
Joint-stock company
LinkedIn URL
@company/eutilex
Location
Seoul
Geumcheon District
0
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
1
Phone Number
+82220713310
+82220713320
Pitchbook URL
pitchbook.com/profiles...168778-27
Exchange
KOSDAQ
Korea Exchange
Stock Symbol
263050
Total Funding Amount (USD)
18,900,000
Official Website
eutilex.com
eutilex.com/eng/home.php
Find more companies like Eutilex
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE